Australia markets open in 34 minutes

Merrimack Pharmaceuticals, Inc. (MACK)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.00-0.03 (-0.20%)
At close: 04:00PM EDT
15.00 0.00 (0.00%)
After hours: 06:09PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 217.98M
Enterprise value 199.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)11.63
Enterprise value/revenue N/A
Enterprise value/EBITDA -91.50

Trading information

Stock price history

Beta (5Y monthly) 1.43
52-week change 315.62%
S&P500 52-week change 322.38%
52-week high 315.89
52-week low 311.53
50-day moving average 314.72
200-day moving average 313.20

Share statistics

Avg vol (3-month) 3142.24k
Avg vol (10-day) 3120.46k
Shares outstanding 514.53M
Implied shares outstanding 614.56M
Float 89.4M
% held by insiders 11.21%
% held by institutions 166.14%
Shares short (15 Apr 2024) 4815.87k
Short ratio (15 Apr 2024) 46.51
Short % of float (15 Apr 2024) 47.99%
Short % of shares outstanding (15 Apr 2024) 45.61%
Shares short (prior month 15 Mar 2024) 4729.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 323 Dec 2019
Ex-dividend date 413 Dec 2019
Last split factor 21271:1000
Last split date 306 Sept 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-6.97%
Return on equity (ttm)-6.22%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-1.18M
Diluted EPS (ttm)-0.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.88M
Total cash per share (mrq)1.3
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)43.50
Book value per share (mrq)1.31

Cash flow statement

Operating cash flow (ttm)-1.52M
Levered free cash flow (ttm)-1.13M